Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,835 | 532 | 70.1% |
| Travel and Lodging | $2,022 | 9 | 16.0% |
| Entertainment | $966.65 | 2 | 7.7% |
| Honoraria | $750.00 | 1 | 5.9% |
| Education | $32.10 | 11 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $2,805 | 79 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $1,089 | 33 | $0 (2021) |
| Flowonix Medical Incorporated | $1,049 | 3 | $0 (2019) |
| Relievant Medsystems, Inc. | $863.22 | 7 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $846.22 | 95 | $0 (2024) |
| Abbott Laboratories | $786.98 | 30 | $0 (2024) |
| PFIZER INC. | $715.09 | 72 | $0 (2021) |
| Daiichi Sankyo Inc. | $492.98 | 32 | $0 (2019) |
| Vertos Medical, Inc. | $425.46 | 6 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $416.49 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $573.81 | 24 | IDORSIA PHARMACEUTICALS US INC ($178.63) |
| 2023 | $1,751 | 29 | Relievant Medsystems, Inc. ($863.22) |
| 2022 | $430.46 | 11 | Nevro Corp. ($288.04) |
| 2021 | $486.03 | 27 | Abbott Laboratories ($178.06) |
| 2020 | $1,390 | 58 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($814.26) |
| 2019 | $2,342 | 92 | Flowonix Medical Incorporated ($949.36) |
| 2018 | $3,516 | 164 | Nevro Corp. ($1,796) |
| 2017 | $2,117 | 150 | Abbott Laboratories ($261.57) |
All Payment Transactions
555 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.01 | General |
| 10/03/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/05/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Insomnia | ||||||
| 09/05/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Insomnia | ||||||
| 08/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.70 | General |
| 08/08/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Insomnia | ||||||
| 08/08/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $0.44 | General |
| Category: Insomnia | ||||||
| 07/30/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Neuromodulation | ||||||
| 07/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Insomnia | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Gastroenterology | ||||||
| 06/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Neuromodulation | ||||||
| 06/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.28 | General |
| Category: Opioid Analgesic | ||||||
| 05/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: Opioid Analgesic | ||||||
| 04/05/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $97.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/04/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: Pain management | ||||||
| 03/14/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Insomnia | ||||||
| 03/08/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $41.54 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 03/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 03/05/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Pain Management | ||||||
| 02/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $123.49 | General |
| Category: Insomnia | ||||||
| 02/21/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/24/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Insomnia | ||||||
| 01/11/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Pain | ||||||
| 11/03/2023 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Orthopedic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 52 | 5,815 | 19,647 | $3.9M | $1.0M |
| 2022 | 54 | 6,548 | 18,891 | $4.7M | $1.2M |
| 2021 | 52 | 6,487 | 15,740 | $4.2M | $1.1M |
| 2020 | 53 | 5,915 | 16,832 | $4.2M | $1.1M |
All Medicare Procedures & Services
249 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 768 | 4,107 | $587,301 | $352,759 | 60.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 713 | 1,164 | $232,800 | $70,075 | 30.1% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 402 | 606 | $499,950 | $67,379 | 13.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 266 | 304 | $250,800 | $58,886 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 490 | 936 | $121,797 | $56,968 | 46.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 129 | 672 | $79,947 | $44,906 | 56.2% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 145 | 730 | $219,000 | $44,370 | 20.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 78 | 90 | $196,800 | $38,181 | 19.4% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 44 | 49 | $60,000 | $31,091 | 51.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 142 | 679 | $135,800 | $25,985 | 19.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 72 | 119 | $119,816 | $21,020 | 17.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 78 | 92 | $180,400 | $20,677 | 11.5% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 38 | 44 | $91,200 | $18,701 | 20.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 75 | 104 | $62,745 | $17,399 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 138 | 138 | $37,950 | $15,291 | 40.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 72 | 78 | $32,370 | $12,869 | 39.8% |
| 62368 | Electronic analysis and reprogramming of spinal canal drug infusion pump | Office | 2023 | 90 | 421 | $74,517 | $12,168 | 16.3% |
| 62264 | Removal of spinal canal scar tissue, multiple sessions in 1 day | Office | 2023 | 30 | 38 | $53,485 | $11,788 | 22.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 38 | 61 | $62,348 | $10,921 | 17.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 71 | 118 | $92,216 | $10,901 | 11.8% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 38 | 44 | $83,600 | $10,813 | 12.9% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Office | 2023 | 23 | 25 | $49,200 | $10,797 | 21.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 184 | 320 | $27,520 | $10,742 | 39.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 49 | 51 | $115,200 | $9,759 | 8.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 32 | 55 | $66,533 | $7,702 | 11.6% |
About Dr. Christopher Mocek, MD
Dr. Christopher Mocek, MD is a Pain Medicine healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821050618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Mocek, MD has received a total of $12,606 in payments from pharmaceutical and medical device companies, with $573.81 received in 2024. These payments were reported across 555 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,835).
As a Medicare-enrolled provider, Mocek has provided services to 24,765 Medicare beneficiaries, totaling 71,110 services with total Medicare billing of $4.5M. Data is available for 4 years (2020–2023), covering 249 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Little Rock, AR
- Active Since 04/05/2006
- Last Updated 09/07/2016
- Taxonomy Code 208VP0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821050618
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $2,326
- Prometra II (Device) $1,049
- Intracept (Device) $886.13
- BELBUCA (Drug) $852.75
- LYRICA (Drug) $594.97
- XTAMPZA (Drug) $455.21
- mild Device Kit (Device) $425.46
- Amitiza (Drug) $345.11
- SCS IPGs (Device) $310.50
- Morphabond ER (Drug) $301.09
- Omnia (Device) $299.65
- RELISTOR (Drug) $299.43
- Horizant (Drug) $229.94
- BELSOMRA (Drug) $223.48
- Movantik (Drug) $216.35
- BUNAVAIL 2.1 mg 30-count box (Drug) $215.80
- Proclaim Family of SCS IPGs (Device) $215.08
- Xtampza ER (Drug) $212.77
- SPRINT PNS System (Device) $204.63
- QUVIVIQ (Drug) $192.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Little Rock
Johnathan Goree, Md, MD
Pain Medicine — Payments: $402,344
Amir Qureshi, Md, MD
Pain Medicine — Payments: $13,032
Jarna Shah, Md, MD
Pain Medicine — Payments: $8,403
Drew Beasley, Md, MD
Pain Medicine — Payments: $4,678
Melissa Alvarez Perez, M.d, M.D
Pain Medicine — Payments: $3,112
Juan Roman, M.d, M.D
Pain Medicine — Payments: $2,594